Foley Trasimene Acquisition II's common stock is $1.4B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
Foley Trasimene Acquisition II (BFT) currently reports a common stock of $1.4B as of September 2020. Use the charts on this page to explore Foley Trasimene Acquisition II's common stock history and peer comparisons.
Foley Trasimene Acquisition II reported $1.4B in common stock as of September 2020. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current common stock of $1.4B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Foley Trasimene Acquisition II, and consider following BFT for alerts when major investors trade the stock.